Markus Warmuth | BiotechTV

top of page

Monte Rosa Therapeutics' CEO Markus Warmuth updates us on the company's progress in developing molecular glue degraders

The company, which recently had a paper earn a spot on the cover of Science, is progressing ahead with both I&I and oncology indications....

Company News

Jul 24

Monte Rosa's CEO discusses yesterday's data for MRT-2359 in MYC-driven solid tumors

Markus Warmuth describes the PK/PD variables the company is seeing, how safety is shaping up, and a partnership with Roche.

Company News

Oct 18, 2023

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate

bottom of page

Monte Rosa Therapeutics' CEO Markus Warmuth updates us on the company's progress in developing molecular glue degraders

Monte Rosa's CEO discusses yesterday's data for MRT-2359 in MYC-driven solid tumors

Follow BiotechTV

Sponsors

Sponsor Spotlight